UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 82.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 1,346,698 shares of the real estate investment trust's stock after selling 6,335,740 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.19% of Healthpeak Properties worth $27,298,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mizuho Bank Ltd. acquired a new stake in Healthpeak Properties during the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at about $30,000. Covestor Ltd raised its stake in shares of Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after buying an additional 1,152 shares during the last quarter. Kestra Investment Management LLC purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at about $45,000. Finally, Kapitalo Investimentos Ltda purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at about $46,000. Institutional investors and hedge funds own 93.57% of the company's stock.
Insider Transactions at Healthpeak Properties
In other Healthpeak Properties news, CEO Scott M. Brinker acquired 2,750 shares of the firm's stock in a transaction that occurred on Friday, May 9th. The shares were purchased at an average cost of $17.39 per share, for a total transaction of $47,822.50. Following the completion of the acquisition, the chief executive officer now owns 204,613 shares of the company's stock, valued at approximately $3,558,220.07. The trade was a 1.36% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Tommy G. Thompson acquired 5,777 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The stock was acquired at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the acquisition, the director now directly owns 144,290 shares of the company's stock, valued at $2,491,888.30. The trade was a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 29,764 shares of company stock worth $521,909 in the last ninety days. Insiders own 0.23% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on DOC shares. Wedbush reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Scotiabank reduced their price objective on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. Argus restated a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Thursday, May 1st. Finally, Evercore ISI cut their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $23.45.
View Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Price Performance
NYSE:DOC traded down $0.11 during trading hours on Friday, hitting $17.41. 9,932,437 shares of the stock were exchanged, compared to its average volume of 5,129,080. Healthpeak Properties, Inc. has a 52-week low of $16.64 and a 52-week high of $23.26. The firm's fifty day moving average price is $18.16 and its 200 day moving average price is $19.71. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a market cap of $12.10 billion, a P/E ratio of 49.74, a P/E/G ratio of 2.17 and a beta of 1.05.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. During the same period in the previous year, the business earned $0.45 EPS. Healthpeak Properties's quarterly revenue was up 15.9% on a year-over-year basis. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The business also recently announced a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date was Monday, May 19th. Healthpeak Properties's dividend payout ratio is currently 305.00%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.